In addition, CD4+ T cells were shown capable of eradicating tumour cells that do not express MHC-II by mobilizing myeloid cells, which are specialized to process and present peptide epitopes on their MHC-II molecules16–18. This evidence concerns the gene CD4 and neoplasm.